Clinical Trials

Breast Neoplasms

NCT03906669 2023-11-22

WinPro

200 enrolled

Breast Neoplasms

NCT05525481 2023-11-01

PREDICTAM

Phase 4 Unknown

100 enrolled

ER+ Breast Cancer

NCT01579734 2023-06-28

HOT

1,884 enrolled

Breast Neoplasms

NCT00412022 2023-03-24

HOBOE

1,294 enrolled

Breast Neoplasms

NCT02914158 2023-01-17

ASPAIT

680 enrolled

Breast Neoplasms

NCT05669768 2023-01-03

Study on the Efficacy and Toxicity of Pamiparib Combined With Tamoxifen in the Treatment of Epithelial Ovarian Cancer Patients With Biochemical Recurrence During First-line PARPi Maintenance Therapy

46 enrolled

Gynecologic

Ovarian Neoplasms

NCT05501158 2022-08-19

CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian Population

150 enrolled

Breast Neoplasms

NCT05133674 2022-05-25

Therapeutic Dose Monitoring (TDM) of Tamoxifen

40 enrolled

Breast Neoplasms

NCT05016349 2021-08-23

Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.

160 enrolled

Breast Cancer Female

NCT01758146 2020-03-04

Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors

412 enrolled

BreastOther

Breast Neoplasms, Obesity

NCT00541086 2020-02-07

Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery

3,697 enrolled

Breast Neoplasms

NCT03024580 2019-08-15

MEGA

20 enrolled

Breast Neoplasms

NCT04046159 2019-08-06

Radiotherapy Versus Low-Dose Tamoxifen Following Breast Conserving Surgery for Low-Risk Breast Ductal Carcinoma in Situ

810 enrolled

Carcinoma, Intraductal, Noninfiltrating

NCT04023292 2019-07-17

Comparative Study for the Degree of Biological Changes After Short-term 2 Weeks and 4 Weeks Preoperative Endocrine Therapy in Luminal Breast Cancer

185 enrolled

Breast Neoplasms

NCT03879174 2019-03-18

Pembro

25 enrolled

Breast Cancer Female

NCT03137368 2018-10-31

STEP

300 enrolled

Breast Neoplasms

NCT03351062 2017-11-22

Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer

844 enrolled

Breast Neoplasms

NCT03211572 2017-07-07

OTT 17-01

82 enrolled

Breast Neoplasms

NCT02513849 2017-05-09

Tamoxifen in Patients With Oesophageal Cancer

Phase 1 Unknown

20 enrolled

Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

NCT02467686 2017-03-20

Cimicifuga

Phase 4 Unknown

60 enrolled

Sexuality

NCT02097459 2016-05-25

Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer

600 enrolled

Breast Neoplasms

NCT01503905 2016-05-24

Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients

600 enrolled

Amenorrhea, Breast Neoplasms

NCT02488603 2015-07-02

Decision Aids for Tamoxifen Treatment in Breast Cancer Patients

360 enrolled

Breast Neoplasms

NCT02482740 2015-06-26

TGOG1005

44 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02132000 2014-05-06

Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer Patients

Phase 2/3 Unknown

3,036 enrolled

Breast Cancer Patients in Premenopausal

NCT00489944 2014-01-10

Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma

50 enrolled

Dermatologic

Uveal Melanoma

NCT00492505 2014-01-10

Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma

200 enrolled

Dermatologic

Melanoma

NCT00492687 2014-01-10

Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas

80 enrolled

CNSSarcoma

Astrocytoma, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00003418 2013-12-19

Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer

4,400 enrolled

Breast Neoplasms

NCT00003678 2013-12-19

Tamoxifen in Treating Women With Breast Cancer

20,000 enrolled

Breast Neoplasms

NCT00010140 2013-12-18

Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer

Breast Neoplasms

NCT00003679 2013-11-06

Combination Chemotherapy in Treating Women With Breast Cancer

350 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00003680 2013-11-06

Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer

300 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT01622361 2013-09-30

NEST

290 enrolled

Breast Neoplasms

NCT00305838 2013-08-12

CA 125 Levels in Treating Patients With Relapsed Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Who Are Receiving Tamoxifen

200 enrolled

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00002460 2013-08-07

Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer

Breast Neoplasms

NCT00024336 2013-08-07

Radiation Therapy and Tamoxifen in Treating Children With Newly Diagnosed Brain Stem Glioma

CNS

Central Nervous System Neoplasms

NCT00629278 2013-08-07

Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer

2,500 enrolled

Breast Neoplasms

NCT00538330 2011-12-13

Post Operative Adjuvant Chemotherapy Followed by Adjuvant Tamoxifen vs Nil for Patients With Operable Breast Cancer

2,000 enrolled

Breast Neoplasms

NCT00896155 2011-08-30

CONSET

260 enrolled

Breast Neoplasms, Pulmonary Fibrosis

NCT00398489 2010-11-09

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

94 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00912548 2009-06-16

ASTRRA

1,234 enrolled

Breast Neoplasms

NCT00033683 2009-02-09

Combination Chemotherapy in Treating Women With Resected Breast Cancer

Breast Neoplasms

NCT00077168 2009-02-09

Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole

2,000 enrolled